Patient Controlled Subcutaneous Analgesia of Hydromorphone Versus Morphine to Treat Moderate and Severe Cancer Pain: A Randomized Double-Blind Controlled Trial

Hydromorphone and morphine are the common drugs used for the treatment of moderate to severe cancer pain. Patient controlled subcutaneous analgesia (PCSA) is an effective technique to manage cancer pain. However, few studies have been conducted to show the efficacy and safety of PCSA of hydromorphone for the relief of cancer pain.

https://www.jpsmjournal.com/article/S0885-3924(23)00689-9/fulltext?rss=yes

Source: Journal of Pain and Symptom Management - September 22, 2023 Category: Palliative Care Authors: Xianzheng Zeng, Jiang Zhu, Jun Li, Chan Chen, Ling Sang, Maotong Liu, Li Song, Hui Liu Tags: Original Article Source Type: research